DGKK's Role in Neurodegenerative Diseases (G139189)

Target Name: DGKK

NCBI ID: G139189

DGKK

DGKK's Role in Neurodegenerative Diseases

Diglyceride kinase kappa (DGKK) is a protein that is expressed in various tissues throughout the body. It is a key enzyme in the lipid metabolism, which is responsible for the breakdown of dietary lipids to produce energy. DGKK is also involved in the regulation of cellular signaling pathways, including the sonic hedgehog pathway. This pathway is a critical regulator of cell growth, development, and survival, and is implicated in a wide range of diseases, including cancer, obesity, and neurodegenerative diseases.

DGKK has also been identified as a potential drug target in the field of neurodegenerative diseases. The sonic hedgehog pathway is a key regulator of neuronal development and function, and DGKK is involved in the breakdown of the sonic hedgehog pathway, which has been implicated in the development and progression of a wide range of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease.

In addition to its role in the sonic hedgehog pathway, DGKK is also involved in the regulation of cellular signaling pathways that are important for the development and maintenance of the nervous system. One of these pathways is the TGF-β pathway, which is involved in the regulation of cell growth, differentiation, and survival. DGKK is involved in the breakdown of TGF-β signaling, which has been implicated in the development and progression of a wide range of neurodegenerative diseases.

DGKK is also involved in the regulation of the NF-kappa-B pathway, which is involved in the regulation of inflammation and immune responses. The NF-kappa-B pathway is a critical regulator of inflammation, and DGKK is involved in the regulation of its activity, which has been implicated in the development and progression of a wide range of neurodegenerative diseases.

In addition to its role in the sonic hedgehog pathway, DGKK is also involved in the regulation of cellular signaling pathways that are important for the development and maintenance of the endoplasmic reticulum, which is the membrane-bound system for the transport and processing of proteins. The endoplasmic reticulum is an important regulator of the delivery of proteins to the cell surface, and DGKK is involved in the regulation of its activity, which has been implicated in the development and progression of a wide range of neurodegenerative diseases.

DGKK is also involved in the regulation of cellular signaling pathways that are important for the development and maintenance of the cytoskeleton, which is the structure that gives cells shape and stability. The cytoskeleton is an important regulator of cell division and the organization of cells, and DGKK is involved in the regulation of its activity, which has been implicated in the development and progression of a wide range of neurodegenerative diseases.

DGKK is also involved in the regulation of cellular signaling pathways that are important for the development and maintenance of the plasma membrane, which is the thin layer of lipids that surrounds each cell. The plasma membrane is an important regulator of the delivery of nutrients and toxins to the cell surface, and DGKK is involved in the regulation of its activity, which has been implicated in the development and progression of a wide range of neurodegenerative diseases.

In conclusion, DGKK is a protein that is involved in a wide range of cellular signaling pathways that are important for the development and maintenance of the body. Its role in the sonic hedgehog pathway, the TGF-β pathway, the NF-kappa-B pathway, and the regulation of the endoplasmic reticulum, cytoskeleton, and plasma membrane is important for the maintenance of cellular homeostasis and the regulation of cellular signaling pathways that are important for the development and maintenance of the nervous system and other tissues. As a result, DGKK is a potential drug target for a wide range of neurodegenerative diseases. Further research is needed to fully understand the role of DGKK in

Protein Name: Diacylglycerol Kinase Kappa

Functions: Diacylglycerol kinase that converts diacylglycerol/DAG into phosphatidic acid/phosphatidate/PA and regulates the respective levels of these two bioactive lipids (PubMed:16210324, PubMed:23949095). Thereby, acts as a central switch between the signaling pathways activated by these second messengers with different cellular targets and opposite effects in numerous biological processes (Probable)

The "DGKK Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DGKK comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets